Oral suspension 400 mg/80 mg /5mL: 120 mL bottle + measuring spoon.

COMPOSITION:

Each coated tablet contains: Trimethoprim 160 mg and Sulfamethoxazole 800 mg. (CO-TRIMOXAZOLE).

Each 5 mL teaspoon contains:

trimethoprim 80 mg and sulfamethoxazole 400 mg. (CO-TRIMOXAZOLE)

INDICATIONS: Broad-spectrum chemobactericide, recommended for: Acute and chronic infections of the urinary tract, caused by E. coli, P. mirabilis or Klebsiella pneumoniae. Prophylaxis in women with multiple reinfections

Acute and chronic bacterial prostatitis.

Acute gastroenteritis, caused by Salmonella, Shigella and E. coli.

Typhoid, including resistant to chloramphenicol and ampicillin.

Otitis media and exacerbations of chronic bronchitis, caused by Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae.

Pneumocystis carinii pneumonia in patients with AIDS.

DOSE: Meprimforte can be administered with or without food.

The usual dose is one Meprimforte tablet every 12 hours for 7 to 14 days, depending on the infection. In uncomplicated cystitis in women: one tablet every 12 hours for 3 days. In bacterial gastroenteritis: 1 tablet every 12 hours for 5 days. In prevention of recurrences of urinary tract infections ½ tablet 3 times a week for several months.

Dose in adults and children over 12 years: 1 tablet every 12 hours

Dose in children: 8 mg/kg/day of the trimethoprim dose or 40 mg/kg/day of the sulfamethoxazole dose, divided every 12 hours.

CONTRAINDICATIONS AND PRECAUTIONS:

Patients hypersensitive to cotrimoxazole.

Term pregnant women.

Under 2 months of age.

Cotrimoxazole is not recommended during pregnancy or lactation.

It should not be co-administered with metheneamine.

COMPOSITION: Each 5 mL teaspoon contains: Trimethoprim 40 mg and Sulfamethoxazole 200 mg. (CO-TRIMOXAZOLE)

INDICATIONS: The main indications: Acute and chronic infections of the urinary tract, caused by E. coli, P. mirabilis or Klebsiella pneumoniae. Prophylaxis in women with multiple reinfections

Acute and chronic bacterial prostatitis.

Acute gastroenteritis, caused by Salmonella, Shigella and E. coli.

Typhoid, including resistant to chloramphenicol and ampicillin.

Otitis media and exacerbations of chronic bronchitis, caused by Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae.

Pneumocystis carinii pneumonia in patients with AIDS.

DOSE: Meprim can be administered with or without food.

Gastrointestinal infections: 40 – 60 / 8 – 10 mg/kg/day divided into 2 doses.

Airway and Urinary Tract Infections: 20 -30 /4 -6 mg/kg/12 hours for 10 days.

CONTRAINDICATIONS and PRECAUTIONS:

Patients hypersensitive to cotrimoxazole.

Term pregnant women.

Under 2 months of age.

Cotrimoxazole is not recommended during pregnancy or lactation.

It should not be co-administered with metheneamine.

COMPOSITION: Each tablet contains 200 mg and 400 mg Ofloxacin. Excipients c.s.p. Ofloxacin is aquinolone with broad-spectrum bactericidal action.

INDICATIONS: UROSTAT® is indicated for the treatment of adults with infections caused by susceptible strains. It has been used in the treatment of a wide range of infections: acute gonorrhea, uncomplicated urethral and cervical cancer. Non-gonococcal urethritis and cervicitis. Mixed infections of the urethra and cervix due to Chlamydia trachomatis and Neisseriagonorrhoeae. Acute pelvic inflammatory disease. Uncomplicated cystitis and complex urinary tract infections. Prostatitis: other infections: Acute bacterial exacerbation of chronic bronchitis and community-acquired pneumonia, uncomplicated infections of the skin and its annexes.

DOSAGE AND ADMINISTRATION: Ofloxacin is administered orally. The usual adult dose is 200 to 400 mg every 12 hours in patients with normal renal function.

SIDE EFFECTS: The most frequently reported adverse effects related to the drug are nausea, insomnia, headache, dizziness, diarrhea, vomiting, rash, pruritus, external genital pruritus in women, vaginitis, dysgeusia.

PRECAUTIONS: In patients with epilepsy or history of CNS diseases. In patients with impaired liver or kidney functions. Avoid drinking alcohol. You can interact with oral hypoglycemic agents or insulin, antacids, iron preparations, opioids, theophylline and warfarin. Pregnancy: Category C.

CONTRAINDICATIONS: Not recommended for children and adolescents, pregnant women and nursing mothers.

COMPOSITION: Each 500 mg coated tablet contains 500 mg of Azithromicindihydrate equivalent to 500 mg of Azithromycin basis.

POWDER FOR SUSPENSION: Each 5 mL of suspension contain 200 mg of Azithromycin basis.

USES AND ADMINISTRATION: For the treatment of infections caused by susceptible bacteria, including otitis media, pharyngitis, tonsillitis, respiratory tract and skin infections. It is used for the treatment of infections by Mycrobacteriumaviumcomplex (MAC), in the prophylaxis of bacterial endocarditis. It has been tested in toxoplasmosis, chlamydia, and gonorrhea. It is administered orally as dehydrate; the doses are administered in terms of the base. Doses should be administered at least one hour after or two hours before meals. The usual dose is 500 mg daily in single dose for 3 days. An alternative is to administer an initial dose of 500 mg followed by 250 mg daily for 4 days more. The usual dose for uncomplicated genital infections due to Chlamydia trachomatis is 1 gram azithromycin as a single dose. A single 2 g dose can be given for uncomplicated gonorrhea. For prophylaxis of MAC disseminated infections 1.2 g of azithromycin is administered a week. For other infections produced by susceptible organisms, including otitis media, respiratory tract infections and skin infections, the suggested dose for children is 10mg per kilogram of body weight once a day for 3 days. An alternative is to administer an initial dose of 10 mg per kilogram of body weight and followed by 5 mg per kilogram of body weight daily followed by 4 days more.
Azithromycin is used in the treatment of infections by Mycobacteiumavium.

ADVERSE EFFECTS AND PRECAUTIONS: Gastrointestinal discomforts are most common side effects, being usually mild. Class FDA: 1B. Pregnancy: Category B.
CONTRAINDICATIONS: Patients with a history of sensitivity reactions to Azithromycin or any other macrolide.

DRUG INTERACTIONS: Other drugs may interact with Azithromycin. Consult your physician if you are taking anticoagulants (such as warfarin), anticonvulsants (such as phenytoin or carbamazepine), and antihistamines (especially terfenadine and theophylline). Antacids containing aluminum or
magnesium can interfere with the absorption of Azithromycin. The use of Azithromycin and antacid must be separated at least 2 hours.